See our new privacy terms at https://privacy.abbvie/.
THE JUVÉDERM® COLLECTION IS
Each product in the JUVÉDERM® Collection is specifically designed,
so you can customize treatment for your patients’ aesthetic goals.
Music playing
JAWLINE1
CHEEKS AND CHIN2
LINES3,6
LIPS4,8
UNDEREYES8
Actual patients. Results may vary.
*Based on a March 2022 provider survey.9
Actual patient treated with JUVÉDERM® VOLUX® XC in the jawline. Results may vary.
G': Resistance to shearing/twisting determines gel firmness7,10,11
G'=g prime.
*Gel properties assessed in vitro. Clinical significance has not been established.
Cohesivity: Resistance to compression contributes to gel spreadability7,11,12
*Gel properties assessed in vitro. Clinical significance has not been established.
Water affinity: Ability to absorb water for a plumping effect5,10,11,13
*Gel properties assessed in vitro. Clinical significance has not been established.
HA concentration: the amount of hyaluronic acid in gel1-4,6,8
*Gel properties assessed in vitro. Clinical significance has not been established.
THE JUVÉDERM® COLLECTION OF FILLERS CONSISTS OF THE WIDEST VARIETY OF HA CONCENTRATIONS THAT ARE
SPECIFICALLY DESIGNED WITH UNIQUE GEL PROPERTIES.1-4,6,8,14-26
Music playing
The JUVÉDERM® Collection of Fillers is the only collection of fillers that uses a certified ergonomic syringe designed for comfort to improve your injecting experience. Each syringe design is color-coded by product for easy differentiation.27,28
Results from the in-practice ergonomic performance testing of the JUVÉDERM®
ergonomic syringe with experienced practitioners.27
Curved thumb rest for improved injection comfort27
Rubber edges for minimal muscle fatigue27
Molded finger grip and contoured design for enhanced grip27
JUVÉDERM® VOLUMA® XC is a structural gel for adding volume to lift and contour.
Gel properties assessed in vitro. Clinical significance has not been established.
The G' and cohesivity of JUVÉDERM® VOLUMA® XC work together to
contribute to lift capacity. G'/firmness alone is not a predictor of lift capacity.12
Actual patient treated with JUVÉDERM® VOLUMA® XC in the cheeks. Results may vary.
JUVÉDERM® VOLUMA® XC provides
natural-looking and lasting results in the
cheeks that last up to 2 years with optimal treatment.2,29
Derived from preclinical studies evaluating gel properties. Clinical significance has not been established.
JUVÉDERM® VOLUMA® XC is a highly moldable, firm gel, meaning it can be sculpted and massaged at initial injection but will retain its shape.7
JUVÉDERM® VOLUMA® XC provides results that can last up to 1 year in the chin with optimal treatment.2
Actual patient treated with JUVÉDERM® VOLUMA® XC in the chin. Results may vary.
70% improved ≥1 point on the Allergan Loss of Jawline Definition Scale (ALJDS)
compared with control at 6 months and 61.3% through 12 months.1
of patients were satisfied
with their treatment results33*
of patients would recommend to a
friend at 6 months, with 87% continuing
to recommend at 12 months34
of patients showed global
aesthetic improvement on the GAIS
at 3 months, which persisted to
nearly 80% at 12 months, as assessed
by evaluating investigators34
Patients had immediate reduction
in jowling in the lower face1,32,35
*At 1-month follow-up, with optimal treatment.33
GAIS=Global Aesthetic Improvement Scale.
G': Resistance to shearing/twisting
determines gel firmness7,10,11
Cohesivity: Resistance to compression
contributes to gel spreadability7,11,12
Gel properties assessed in vitro. Clinical significance has not been established.
Actual patient treated with JUVÉDERM® VOLUX® XC in the jawline. Results may vary.
JUVÉDERM® ULTRA PLUS XC
Robust gel for moderate to severe facial wrinkles and folds.7,13
JUVÉDERM® VOLLURE® XC
Smooth and balanced gel for moderate to severe facial wrinkles and folds.7,13
Gel properties assessed in vitro. Clinical significance has not been established.
The images above depict tissue integration of JUVÉDERM® Ultra Plus XC and JUVÉDERM® VOLLURE® XC in animal models. The filler gel, in blue, integrates into the surrounding collagenous dermis tissue, in red.3,6
*Gel properties assessed in vitro. Clinical significance has not been established.
†With optimal treatment.
Actual patient treated with JUVÉDERM® VOLBELLA® XC in the lips. Results may vary.
JUVÉDERM® ULTRA XC
Plump gel for lip augmentation.4,5,7,13
JUVÉDERM® VOLBELLA® XC
Soft gel for subtle volume.7,13
Gel properties assessed in vitro. Clinical significance has not been established.
Different HA concentrations contribute to:
Subtle volume with JUVÉDERM® VOLBELLA® XC
plump with JUVÉDERM® Ultra XC4,8,10
*Gel properties assessed in vitro. Clinical significance has not been established.
†Based on duration data obtained from the clinical study in the JUVÉDERM® Ultra XC Directions for Use (DFU), July 2020, JUVÉDERM® VOLBELLA® XC DFU,
November 2021, Restylane® Silk Instructions for Use (IFU), May 2020, Restylane® Kysse IFU, March 2020, Restylane® IFU, May 2020, and the Revanesse®
Lips™+ DFU, 2020. Not a head-to-head study.4,8,16,19,20,23
‡With optimal treatment.4,8
The eye area is a top concern for patients,* and subtle volume is appropriate for treating the delicate infraorbital hollows area. JUVÉDERM® VOLBELLA® XC has moderate G', low water affinity, and low cohesivity, making it a suitable product for the treatment of undereye hollows.7,8,13,37,38
Gel properties assessed in vitro. Clinical significance has not been established.
Actual patient treated with JUVÉDERM® VOLBELLA® XC in the infraorbital hollows. Results may vary.
*According to an online survey of 603 women and 600 men aged 30 to 65 years who were considering aesthetic treatments.37,38
Since 2006, JUVÉDERM® has been a leader in HA dermal filler innovation.7,11,12
VIEW MORE
New to JUVÉDERM® and Allergan
Aesthetics? Open an account and learn more today.
JUVÉDERM® Collection of Fillers INDICATIONS AND IMPORTANT SAFETY INFORMATION
JUVÉDERM® VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face and for augmentation of the chin region to improve the chin profile in adults over the age of 21.
JUVÉDERM® VOLUX® XC injectable gel is indicated for subcutaneous and/or supraperiosteal injection for improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.
JUVÉDERM® VOLLURE® XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.
JUVÉDERM® VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and correction of perioral rhytids, and for the improvement of infraorbital hollowing in adults over the age of 21.
JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
JUVÉDERM® Ultra XC injectable gel is also indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.
The most common reported side effects for JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also reported. The majority were mild or moderate in severity.
To report an adverse reaction with any product in the JUVÉDERM® Collection, please call Allergan® Product Support at 1-877-345-5372. Please visit rxabbvie.com for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-voluma-xc_dfu.pdf for JUVÉDERM® VOLUMA® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-volux-xc_dfu.pdf for JUVÉDERM® VOLUX® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-vollure-xc_dfu.pdf for JUVÉDERM® VOLLURE® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-volbella_dfu.pdf for JUVÉDERM® VOLBELLA® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-ultra-plus-xc_dfu.pdf for JUVÉDERM® Ultra Plus XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-ultra-xc_dfu.pdf for JUVÉDERM® Ultra XC
JUVÉDERM® Collection of Fillers INDICATIONS AND IMPORTANT SAFETY INFORMATION
JUVÉDERM® VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face and for augmentation of the chin region to improve the chin profile in adults over the age of 21.
JUVÉDERM® VOLUX® XC injectable gel is indicated for subcutaneous and/or supraperiosteal injection for improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.
JUVÉDERM® VOLLURE® XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.
JUVÉDERM® VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and correction of perioral rhytids, and for the improvement of infraorbital hollowing in adults over the age of 21.
JUVÉDERM® Ultra Plus XC and JUVÉDERM® Ultra XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
JUVÉDERM® Ultra XC injectable gel is also indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.
The most common reported side effects for JUVÉDERM® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM® VOLBELLA® XC, dryness was also reported. The majority were mild or moderate in severity.
To report an adverse reaction with any product in the JUVÉDERM® Collection, please call Allergan® Product Support at 1-877-345-5372. Please visit rxabbvie.com for more information.
Products in the JUVÉDERM® Collection are available only by a licensed physician or properly licensed practitioner.
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-voluma-xc_dfu.pdf for JUVÉDERM® VOLUMA® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-volux-xc_dfu.pdf for JUVÉDERM® VOLUX® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-vollure-xc_dfu.pdf for JUVÉDERM® VOLLURE® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-volbella_dfu.pdf for JUVÉDERM® VOLBELLA® XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-ultra-plus-xc_dfu.pdf for JUVÉDERM® Ultra Plus XC
Please see Directions for Use or visit https://www.rxabbvie.com/pdf/juvederm-ultra-xc_dfu.pdf for JUVÉDERM® Ultra XC